- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 27th, 2003
Altair Nanotechnologies Testing RenaZorb With 2nd Pharm. Co.
Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced that it has entered into a testing agreement with a second pharmaceutical company for in vivo (animal) evaluation of RenaZorb(TM), its new pharmaceutical candidate for phosphate control in kidney dialysis patients.
|Related News Press|
Silk bio-ink could help advance tissue engineering with 3-D printers September 2nd, 2015
Using DNA origami to build nanodevices of the future September 1st, 2015